Skip to main content
. 2017 Dec 22;8:724. doi: 10.3389/fneur.2017.00724

Figure 1.

Figure 1

(A) MRI shows pontocerebellar lesion with incomplete peripheral enhancement. (B) Elevated IFNγ response against neurofascin (NF)155 and NF186 before clinical manifestation in Elispot assay. (C) Follow-up MRI shows new lesion in the middle cerebellar peduncle and adjacent pons without clinical manifestation or contrast enhancement. (D) Follow-up Elispot assay shows no IFNγ response against NF.